Conveners
Session 2: Novel and Emerging Pathogens
- Fabian Leendertz
- Maximilian Rohde
-
Tomas Moutinho (University of São Paulo)10/5/26, 2:00 PMNovel and Emerging PathogensOral presentation
Background: Integrated field data from Brazil's biodiverse, fast-changing biomes are scarce. We will investigate the human–animal–environment interface in two different Brazilian biomes: the Pantanal and the Cerrado.
Methods: In a cross-sectional One Health survey, following ethical approval for both human and animal research, 147 rural residents underwent a sociodemographic questionnaire...
Go to contribution page -
Dr Fanny Hellhammer (TiHo Hannover AG VABI)10/5/26, 2:15 PMNovel and Emerging PathogensOral presentation
We conducted a prospective multicentre seroepidemiological study including 2,283 febrile patients from Côte d’Ivoire and Gabon between 2022 and 2024. IgG antibodies against dengue virus (DENV), Zika virus, West Nile virus, and Rift Valley fever virus were assessed using a novel high-specificity ELISA platform designed to reduce flaviviral cross-reactivity. Plasmodium infection was determined...
Go to contribution page -
Dr Arthur Wickenhagen (1 Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA 2 Laboratory for Host-Virus Systems and Transmission, Helmholtz Institute for One Health (HIOH), Helmholtz Centre for Infection Research (HZI), Greifswald, Germany)10/5/26, 2:30 PMNovel and Emerging PathogensOral presentation
Highly pathogenic avian influenza A virus (H5N1) continues to circulate globally in wild birds and is increasingly detected in mammals, highlighting the risk of cross-species transmission. Serological evidence of exposure in South American vampire bats and reports of H5N1-positive flying foxes in Bangladesh suggest that bats are susceptible to infection. However, their role in H5N1 ecology...
Go to contribution page -
Selina L. Graff (Institute of Virology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany)10/5/26, 2:45 PMNovel and Emerging PathogensOral presentation
Ekpoma virus 2 (EKV-2) is a human-associated rhabdovirus first detected in a febrile case in Nigeria. Seroprevalence studies from Nigeria and the Democratic Republic of Congo (DRC) reported EKV-2 reactivity rates ranging from 4 – 94%. EKV-2 is closely related to Mundri virus (MUNV), identified in the cerebrospinal fluid of a girl with nodding syndrome in South Sudan, and to Bas-Congo virus...
Go to contribution page -
Dr Isabel von Creytz (Center for Biological Threats and Special Pathogens, Robert Koch Institute, 13343 Berlin, Germany)10/5/26, 3:00 PMNovel and Emerging PathogensOral presentation
Andes virus (ANDV) and Ebola virus (EBOV) are zoonotic pathogens that cause related severe vascular disease despite belonging to distinct virus families. So far, it is poorly understood whether unrelated viral hemorrhagic fevers elicit common or divergent host responses in the human vasculature.
Go to contribution page
To address this, we generated highly pure artery and vein endothelial cells (ECs) from human... -
Ariane Düx (Helmholtz Institute for One Health)10/5/26, 3:15 PMNovel and Emerging PathogensOral presentation
Mpox is an emerging zoonosis caused by the monkeypox virus (MPXV) which is endemic in West and Central Africa. Most zoonotic MPXV spillovers cause isolated cases or short transmission chains, but lineages showing sustained human-to-human transmission have recently spread. Rodents are thought to be MPXV reservoirs, but conclusive evidence linking human mpox cases to these animals is lacking....
Go to contribution page
